Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 13/20 | 0.67 |
| ▸ | CCKBR | P32239 | 2/20 | 0.67 |
| ▸ | GCGR | P47871 | 3/20 | 0.67 |
| ▸ | CALCR | P30988 | 4/20 | 0.65 |
| ▸ | NPY1R | P25929 | 1/20 | 0.65 |
| ▸ | NPY2R | P49146 | 1/20 | 0.65 |
| ▸ | NPY4R | P50391 | 1/20 | 0.65 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658376 | 0.93 | NPY1R (0.70) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL30721635 | 0.93 | GLP1R (0.70) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL30901423 | 0.92 | GLP1R (0.70) | GLP1RCCKBRGCGRCALCR | |
| SCHEMBL30721629 | 0.91 | GLP1R (0.70) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL30721573 | 0.91 | NPY1R (0.72) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL30721579 | 0.91 | NPY1R (0.72) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL31182774 | 0.91 | GLP1R (0.65) | GLP1RCCKBRCALCRNPY1RNPY2R | |
| SCHEMBL31202689 | 0.91 | CALCR (0.73) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL29991271 | 0.91 | GLP1R (0.73) | GLP1RCCKBRGCGRCALCRNPY1R | |
| SCHEMBL30658220 | 0.91 | GLP1R (0.72) | GLP1RCCKBRGCGRCALCRNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |